Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies
US11130801B2 · kind B2 · utility
6Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 13, 2012 |
| Grant date | Sep 28, 2021 |
| Priority date | — |
| Expiry date | Jan 13, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of modulating growth factor responses of cells expressing C3a receptor (C3aR) and C5a receptor (C5aR) and at least one growth factor receptor includes administering to the cells at least one agent that modulates C3aR and/or C5aR signaling of the cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.